Qualitat Genesus Private Limited
About Qualitat Genesus Private Limited
Data last updated:
Qualitat Genesus Private Limited is a private limited company based in Chandigarh, India. It operates in the paper and paper products segment of the paper and packaging sector. It was incorporated on 03 July 2024.
The company is registered with the Registrar of Companies (ROC), Chandigarh, under CIN U21005CH2024PTC045775.
The company has an authorised share capital of ₹15 Lakh and a paid-up capital of ₹1 Lakh. It is led by directors Anant Berry and Anil Berry.
Its last annual general meeting (AGM) was held on 30 September 2025, and its latest financial statements are for the year ended 31 March 2025. The registered office is at Plot No. 805, Industrial Area Phase – 2, Chandigarh, India – 160002.
As per the financials filed for FY 2025, the company reported a revenue of ₹61.4 Lakh. For the same year it recorded a net profit of ₹15,770 (net margin 0.3%) and EBITDA of ₹21,030 (EBITDA margin 0.3%).
As per MCA filings, the company has open charges of ₹1.5 Cr on record.
Company details
Contact details
Qualitat Genesus Private Limited's registered office is in Chandigarh, Chandigarh.
- Registered AddressPlot No. 805, Industrial Area Phase – 2, Chandigarh, India – 160002
- IndustryPaper, Paper & Paper Products, Manufacturing
- Company details, directors and signatories
- Historical financials and ratios
- Shareholding pattern and group structure
- Charges with holder and property details
- Legal cases, compliance and MCA filings
Financials of Qualitat Genesus Private Limited
FY 2025 filings availableQualitat Genesus Private Limited reported revenue of ₹61.4 Lakh for FY 2025.
Financial Statement Summary
| Metrics | FY 2024-25 |
|---|---|
| Profit and Loss Statement | |
| Revenue from Operations | |
| Other Income | |
| Total Revenue | |
| Cost of Materials Consumed | |
| Employee Benefit Expense | |
| Finance Costs | |
| Depreciation and Amortisation | |
| Other Expenses | |
| Total Expenses | |
| EBITDA | ₹21,030 |
| Profit Before Tax | |
| Tax Expense | |
| Net Profit (PAT) | ₹15,770 |
| Balance Sheet | |
| Share Capital | |
| Reserves and Surplus | |
| Net Worth (Total Equity) | |
| Long-term Borrowings | |
| Short-term Borrowings | |
| Trade Payables | |
| Total Liabilities | |
| Fixed Assets | |
| Investments | |
| Inventories | |
| Trade Receivables | |
| Cash and Bank Balance | |
| Total Assets | |
Financial Ratios
| Metrics | FY 2024-25 |
|---|---|
| Profitability | |
| EBITDA Margin | 0.3% |
| Net Profit Margin | 0.3% |
| Return on Equity (ROE) | |
| Return on Capital Employed (ROCE) | |
| Return on Assets (ROA) | |
| Liquidity and Debt | |
| Current Ratio | |
| Quick Ratio | |
| Debt-to-Equity Ratio | |
| Interest Coverage Ratio | |
| Efficiency and Growth | |
| Asset Turnover | |
| Receivable Days | |
| Payable Days | |
| Inventory Days | |
| Revenue Growth | |
| Net Profit Growth | |
To see the full financial statements and ratios of Qualitat Genesus Private Limited, buy the company report.
Board of directors of Qualitat Genesus Private Limited
Qualitat Genesus has 2 directors on record. No former directors are listed.
| Name | Designation | Appointment Date | Tenure | Status |
|---|---|---|---|---|
| Anant Berry | Director | 03 Jul 2024 | 2 Years 3 Months | Current |
| Anil Berry | Director | 03 Jul 2024 | 2 Years 3 Months | Current |
Peer comparison
Qualitat Genesus Private Limited is compared with the 10 companies closest to it by revenue in the Pharma industry (Formulations), from the latest filed financials of each company.
| Company | Revenue | Net profit | Margin | Growth (1 yr) | Employees | Location |
|---|---|---|---|---|---|---|
| Sun Rays Lifesciences Private Limited | ₹61.88 Lakh (FY 2024) | 5.0% | Kanpur, Uttar Pradesh, India | |||
| Elrinon Healthcare Private Limited | ₹61.87 Lakh (FY 2019) | 1.0% | Bangalore, Karnataka, India | |||
| Nelson Labs Private Limited | ₹61.7 Lakh (FY 2025) | 6.0% | New Delhi, Delhi, India | |||
| PRK Formulations Private Limited | ₹61.48 Lakh (FY 2024) | 3.0% | Patna, Bihar, India | |||
| Mezzone Healthcare Private Limited | ₹61.44 Lakh (FY 2016) | New Delhi, Delhi, India | ||||
| Qualitat Genesus Private Limitedthis company | ₹61.4 Lakh (FY 2025) | ₹15,770 | 0.3% | Chandigarh, India | ||
| Kar Therapeutics & Estates Private Limited | ₹61.34 Lakh (FY 2025) | -2.0% | Hyderabad, Telangana, India | |||
| Kilter Cure India Private Limited | ₹61.34 Lakh (FY 2024) | 14.0% | Bangalore, Karnataka, India | |||
| Inhale Pharmaceuticals Private Limited | ₹61.33 Lakh (FY 2024) | 8.0% | Lucknow, Uttar Pradesh, India | |||
| Medarth Biotech Private Limited | ₹61.23 Lakh (FY 2025) | 77.0% | Nagpur, Maharashtra, India | |||
| Esryn Pharma Private Limited | ₹61.18 Lakh (FY 2024) | 1022.0% | Chandigarh, India |
To see the full peer comparison of Qualitat Genesus Private Limited, buy the company report.
Charges & borrowings
| Date | Charge ID | Lender | Amount | Status | Modified or satisfied on |
|---|---|---|---|---|---|
| 24 Jun 2025 | 101119179 | Yes Bank Limited | ₹1.5 Cr | Open |
Total charge records: 1 View all charges
Legal cases
No court or tribunal cases involving Qualitat Genesus Private Limited are on our record; a case search with case numbers, parties and status is in the company report Buy the company report.
MSME payment delays
No delayed payments to MSME suppliers are on our record for Qualitat Genesus Private Limited; the supplier-wise MSME Form 1 check is in the company report Buy the company report.
GST
No GST registration is on our record for Qualitat Genesus Private Limited; the GSTIN and return-filing check is in the company report Buy the company report.
Recent activity
Qualitat Genesus Private Limited has 2 board changes on record since 2024: 2 appointments. The latest: Anant Berry was appointed as Director on 03 Jul 2024.
Frequently asked questions
Qualitat Genesus is an active private limited company based in Chandigarh, India. The company works in paper and paper products, within the paper industry. It was incorporated on 03 July 2024 (2+ years old) and is registered under CIN U21005CH2024PTC045775.
Qualitat Genesus has 2 current directors:
- Anant Berry - Director
- Anil Berry - Director
The latest financial statements of Qualitat Genesus on record with the MCA are for the year ended 31 March 2025. Its last annual general meeting was held on 30 September 2025. Year-wise statements from FY 2025 are in the company report.
The CIN (Corporate Identification Number) of Qualitat Genesus is U21005CH2024PTC045775. It is issued by the Ministry of Corporate Affairs under the Companies Act, 2013, and uniquely identifies the company in India.
Qualitat Genesus was incorporated on 03 July 2024, making it 2+ years old. It is registered with the Registrar of Companies, Chandigarh.
The peers of Qualitat Genesus by revenue are Sun Rays Lifesciences Private Limited, Elrinon Healthcare Private Limited, Nelson Labs Private Limited, PRK Formulations Private Limited, Mezzone Healthcare Private Limited and 5 more, all in the Pharma industry (Formulations).
Anant Berry was appointed as Director on 03 Jul 2024. Anil Berry was appointed as Director on 03 Jul 2024.
The registered office of Qualitat Genesus is at Plot No. 805, Industrial Area Phase – 2, Chandigarh, India – 160002.
Qualitat Genesus operates in the paper industry, in the paper and paper products segment.
Qualitat Genesus has open charges of ₹1.5 Cr and no satisfied charges on record as per latest MCA filings.
Qualitat Genesus can be reached at its registered office: Plot No. 805, Industrial Area Phase – 2, Chandigarh, India – 160002.